These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15576415)

  • 1. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.
    Haringman JJ; Gerlag DM; Zwinderman AH; Smeets TJ; Kraan MC; Baeten D; McInnes IB; Bresnihan B; Tak PP
    Ann Rheum Dis; 2005 Jun; 64(6):834-8. PubMed ID: 15576415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.
    Bresnihan B; Pontifex E; Thurlings RM; Vinkenoog M; El-Gabalawy H; Fearon U; Fitzgerald O; Gerlag DM; Rooney T; van de Sande MG; Veale D; Vos K; Tak PP
    J Rheumatol; 2009 Aug; 36(8):1800-2. PubMed ID: 19671815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.
    Gerlag DM; Haringman JJ; Smeets TJ; Zwinderman AH; Kraan MC; Laud PJ; Morgan S; Nash AF; Tak PP
    Arthritis Rheum; 2004 Dec; 50(12):3783-91. PubMed ID: 15593225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis.
    Kruithof E; De Rycke L; Vandooren B; De Keyser F; FitzGerald O; McInnes I; Tak PP; Bresnihan B; Veys EM; Baeten D;
    Arthritis Rheum; 2006 Jun; 54(6):1795-804. PubMed ID: 16729282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment.
    Kraan MC; Reece RJ; Smeets TJ; Veale DJ; Emery P; Tak PP
    Arthritis Rheum; 2002 Aug; 46(8):2034-8. PubMed ID: 12209505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study.
    Boumans MJ; Houbiers JG; Verschueren P; Ishikura H; Westhovens R; Brouwer E; Rojkovich B; Kelly S; den Adel M; Isaacs J; Jacobs H; Gomez-Reino J; Holtkamp GM; Hastings A; Gerlag DM; Tak PP
    Ann Rheum Dis; 2012 Feb; 71(2):180-5. PubMed ID: 21917822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue.
    Smeets TJ; Kraan MC; van Loon ME; Tak PP
    Arthritis Rheum; 2003 Aug; 48(8):2155-62. PubMed ID: 12905468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers.
    Bresnihan B; Gerlag DM; Rooney T; Smeets TJ; Wijbrandts CA; Boyle D; Fitzgerald O; Kirkham BW; McInnes IB; Smith M; Ulfgren AK; Veale DJ; Tak PP
    J Rheumatol; 2007 Mar; 34(3):620-2. PubMed ID: 17343309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
    van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
    Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.
    Verschueren PC; Lories RJ; Daans M; Théate I; Durez P; Westhovens R; Luyten FP
    Ann Rheum Dis; 2009 Jan; 68(1):117-23. PubMed ID: 18276742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis.
    Baeten D; Houbiers J; Kruithof E; Vandooren B; Van den Bosch F; Boots AM; Veys EM; Miltenburg AM; De Keyser F
    Ann Rheum Dis; 2006 Aug; 65(8):990-7. PubMed ID: 16414969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pulse methylprednisolone on macrophage chemotactic protein-1 and macrophage inflammatory protein-1alpha in rheumatoid synovium.
    Wong PK; Cuello C; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
    J Rheumatol; 2001 Dec; 28(12):2634-6. PubMed ID: 11764208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.
    Vos K; Thurlings RM; Wijbrandts CA; van Schaardenburg D; Gerlag DM; Tak PP
    Arthritis Rheum; 2007 Mar; 56(3):772-8. PubMed ID: 17328049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane.
    Youssef P; Roth J; Frosch M; Costello P; Fitzgerald O; Sorg C; Bresnihan B
    J Rheumatol; 1999 Dec; 26(12):2523-8. PubMed ID: 10606357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD; Celis R; Moll C; Izquierdo E; Marsal S; Sanmartí R; Palacín A; Lora D; de la Cruz J; Pablos JL
    Ann Rheum Dis; 2009 May; 68(5):751-6. PubMed ID: 18495732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial infiltration with CD79a-positive B cells, but not other B cell lineage markers, correlates with joint destruction in rheumatoid arthritis.
    Mo YQ; Dai L; Zheng DH; Zhu LJ; Wei XN; Pessler F; Shen J; Zhang BY
    J Rheumatol; 2011 Nov; 38(11):2301-8. PubMed ID: 22002013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy.
    Youssef PP; Kraan M; Breedveld F; Bresnihan B; Cassidy N; Cunnane G; Emery P; Fitzgerald O; Kane D; Lindblad S; Reece R; Veale D; Tak PP
    Arthritis Rheum; 1998 Apr; 41(4):663-9. PubMed ID: 9550475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
    Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
    Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker.
    Wijbrandts CA; Vergunst CE; Haringman JJ; Gerlag DM; Smeets TJ; Tak PP
    Arthritis Rheum; 2007 Nov; 56(11):3869-71. PubMed ID: 17968928
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammation and vascularisation markers of arthroscopically-guided finger joint synovial biospies reflect global disease activity in rheumatoid arthritis.
    Vordenbäumen S; Sewerin P; Lögters T; Miese F; Schleich C; Bleck E; Philippski P; Schädel-Höpfner M; Pauly T; Schneider M; Ostendorf B
    Clin Exp Rheumatol; 2014; 32(1):117-20. PubMed ID: 24387883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.